Bristol-Myers Squibb, Sandoz, AmerisourceBergen, Genetech and more joining the LogiPharma 2018 Conference Read more
Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin Read more
Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Read more